has slammed COVID-19 vaccine czar Moncef Slaoui’s “huge conflict of interest” after required federal filings revealed he holds $10 million in stock options in one of the companies working to develop a COVID-19 vaccine. It is a huge conflict of interest for the White House’s new vaccine czar to own $10 million of stock in a company receiving government funding to develop a COVID-19 vaccine. https://t.co/8IWLxVL7laSlaoui, a former pharmaceutical executive, was named “chief scientist” on Friday for President Donald Trump’s “Operation Warp Speed,” a COVID-19 vaccine development operation. But Slaoui still owns 155,000 Moderna stock options, totaling more than $10 million as of Friday, according to Business Insider. But health publication Stat News said that it was probably Moderna, the company Slaoui stands to profit from, because he likely had access to that information.

Source: Huffington Post May 17, 2020 04:13 UTC